With CBD projected to be a $450 Million industry in the coming year, FDA hosted a packed house of industry stakeholders last week in a day-long public meeting that was the kickoff of a discussion to determine whether there is a pathway for CBD in ingestible products such as foods and dietary supplements.  See our summary of key themes here https://www.fooddruglaw.com/2019/06/01/fda-cbd-public-meeting-features-overwhelming-calls-for-robust-regulation-and-enforcement-relaxation-of-obstacles-to-research/ and check out this podcast episode to hear five key takeaways.

Visit Kelley Drye's Advertising and Privacy Law Resource Center:

https://www.kelleydrye.com/Advertising-and-Privacy-Law-Resource-Center

CBD: Five Key Takeaways From FDA’s CBD Public Meeting (11:00)

The Ad Law Access podcast, now available daily, is powered by Kelley Drye’s Advertising and Privacy / Data Security teams. 

Hosted by Simone Roach, the daily podcast complements the award-winning Ad Law Access blog, and provides updates and analysis on advertising, marketing, and privacy / data security law.

Please visit the Advertising and Privacy Law Resource Center at https://www.kelleydrye.com/Advertising-and-Privacy-Law-Resource-Center and our award winning blog at https://adlawaccess.com.

CBD: Five Key Takeaways From FDA’s CBD Public Meeting (11:00)

Kelley Drye Ad Law Access Podcast